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Abstract
BACKGROUND  AND  PURPOSE  The  rat  respiratory  muscle  diaphragm  has  markedly  lower
sensitivity  than  the  locomotor  muscle  extensor  digitorum  longus  (EDL)  to  the  new
acetylcholinesterase (AChE) inhibitors, alkylammonium derivatives of 6-methyluracil (ADEMS).
This study evaluated several possible reasons for differing sensitivity between the diaphragm
and limb muscles and between the muscles and the brain. EXPERIMENTAL APPROACH Increased
amplitude and prolonged decay time of miniature endplate currents were used to assess anti-
cholinesterase activity in muscles. In hippocampal slices, induction of synchronous network
activity was used to follow cholinesterase inhibition. The inhibitor sensitivities of purified AChE
from the EDL and brain were also estimated. KEY RESULTS The intermuscular difference in
sensitivity to ADEMS is partly explained caused by a higher level of mRNA and activity of 1,3-
bis[5(diethyl-o-nitrobenzylammonium)pentyl]-6-methyluracildibromide  (C-547)-resistant  BuChE
in the diaphragm. Moreover, diaphragm AChE was more than 20 times less sensitive to C-547
than that from the EDL. Sensitivity of the EDL to C-547 dramatically decreased after treadmill
exercises that increased the amount of PRiMA AChE(G4), but not ColQ AChE(A12) molecular
forms. The A12 form present in muscles appeared more sensitive to C-547. The main form of
AChE in brain, PRiMA AChE(G4), was apparently less sensitive because brain cholinesterase
activity was almost three orders of magnitude more resistant to C-547 than that of the EDL.
CONCLUSIONS AND IMPLICATIONS Our findings suggest that ADEMS compounds could be used
for the selective inhibition of AChEs and as potential therapeutic tools. © 2011 The British
Pharmacological Society.
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